Literature DB >> 25064346

2-(4-Chlorobenzyl)-6-arylimidazo[2,1-b][1,3,4]thiadiazoles: synthesis, cytotoxic activity and mechanism of action.

Sujeet Kumar1, Mahesh Hegde2, Vidya Gopalakrishnan2, Vinaya Kumar Renuka1, Sureshbabu A Ramareddy1, Erik De Clercq3, Dominique Schols3, Anil Kumar Gudibabande Narasimhamurthy4, Sathees C Raghavan2, Subhas S Karki5.   

Abstract

The cytotoxic activity of a new series of 2-(4'-chlorobenzyl)-5,6-disubstituted imidazo[2,1-b][1,3,4]thiadiazoles against different human and murine cancer cell lines is reported. Among the tested compounds, two derivatives namely 2-(4-chlorobenzyl)-6-(2-oxo-2H-chromen-3-yl)imidazo[2,1-b][1,3,4]thiadiazole-5-carbaldehyde 4i and 2-(4-chlorobenzyl)-6-(2-oxo-2H-chromen-3-yl)imidazo[2,1-b][1,3,4]thiadiazol-5-yl thiocyanate 5i emerged as the most potent against all the cell lines. To investigate the mechanism of action, we selected compounds 4i for cell cycle study, analysis of mitochondrial membrane potential and Annexin V-FITC flow cytometric analysis and DNA fragmentation assay. Results showed that 4i induced cytotoxicity by inducing apoptosis without arresting the cell cycle.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anti-cancer drugs; Apoptosis; Cancer therapeutics; Cell death; Cytotoxicity

Mesh:

Substances:

Year:  2014        PMID: 25064346     DOI: 10.1016/j.ejmech.2014.07.054

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  6 in total

1.  Synthesis, Molecular Docking and Preliminary Antileukemic Activity of 4-Methoxybenzyl Derivatives Bearing Imidazo[2,1-b][1,3,4]thiadiazole.

Authors:  B Choodamani; Karla G Cano Hernandez; Sujeet Kumar; Ann Maria Tony; Austre Y Schiaffino Bustamante; Renato J Aguilera; Dominique Schols; C Gopi Mohan; Subhas S Karki
Journal:  Chem Biodivers       Date:  2021-01-07       Impact factor: 2.408

2.  QSAR models of antiproliferative activity of imidazo[2,1-b][1,3,4]thiadiazoles in various cancer cell lines.

Authors:  Joanna Matysiak; Andrzej Niewiadomy
Journal:  Mol Divers       Date:  2016-10-08       Impact factor: 2.943

3.  Combinatorial Study of a Novel Poly (ADP-ribose) Polymerase Inhibitor and an HDAC Inhibitor, SAHA, in Leukemic Cell Lines.

Authors:  Mahesh Hegde; Kempegowda Mantelingu; Monica Pandey; Chottanahalli S Pavankumar; Kanchugarakoppal S Rangappa; Sathees C Raghavan
Journal:  Target Oncol       Date:  2016-10       Impact factor: 4.493

4.  A Benzothiazole Derivative (5g) Induces DNA Damage And Potent G2/M Arrest In Cancer Cells.

Authors:  Mahesh Hegde; Supriya V Vartak; Chandagirikoppal V Kavitha; Hanumappa Ananda; Doddakunche S Prasanna; Vidya Gopalakrishnan; Bibha Choudhary; Kanchugarakoppal S Rangappa; Sathees C Raghavan
Journal:  Sci Rep       Date:  2017-05-31       Impact factor: 4.379

5.  3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pancreatic Ductal Adenocarcinoma.

Authors:  Stella Cascioferro; Giovanna Li Petri; Barbara Parrino; Btissame El Hassouni; Daniela Carbone; Vincenzo Arizza; Ugo Perricone; Alessandro Padova; Niccola Funel; Godefridus J Peters; Girolamo Cirrincione; Elisa Giovannetti; Patrizia Diana
Journal:  Molecules       Date:  2020-01-14       Impact factor: 4.411

Review 6.  Cytotoxic Properties of 1,3,4-Thiadiazole Derivatives-A Review.

Authors:  Sara Janowska; Agata Paneth; Monika Wujec
Journal:  Molecules       Date:  2020-09-20       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.